Clinical Trial Update: High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating high dosage buprenorphine for withdrawal assistance in analgesic opioid use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: High Dosage Buprenorphine | Phase 2 | Status: UNKNOWN